Tom Blundell

From Wikipedia, the free encyclopedia
Jump to: navigation, search
For the New Zealand cricketer, see Tom Blundell (cricketer).
Sir Tom Blundell
Blundell Tom 280306 crop.jpg
Sir Tom Blundell in 2006
Born Thomas Leon Blundell
(1942-07-07) 7 July 1942 (age 74)[1]
Alma mater Brasenose College, Oxford[1]
Thesis The determination by X-ray diffraction methods of the crystal and molecular structures of some coordination compounds (1969)
Doctoral advisor Herbert M Powell, FRS
Doctoral students
Known for
Notable awards
Spouse Dr. Lady Bancinyane Lynn Sibanda Blundell[1]
Children Ricky, Kelesi, Lisa


Sir Thomas Leon "Tom" Blundell, FRS, FMedSci (born 7 July 1942) is a British biochemist, structural biologist, and science administrator. He was a member of the team of Dorothy Hodgkin that solved in 1969 the first structure of a protein hormone, insulin. Blundell has made contributions to the structural biology of polypeptide hormones, growth factors, receptor activation, signal transduction, and DNA double-strand break repair, subjects important in cancer, tuberculosis, and familial diseases. He has developed software for protein modeling and understanding the effects of mutations on protein function, leading to new approaches to structure-guided and fragment-based drug discovery. In 1999 he co-founded the oncology company Astex Therapeutics, which has moved ten drugs into clinical trials. Blundell has played central roles in restructuring British research councils and, as President of the UK Science Council, in developing professionalism in the practice of science.


Insulin monomer

Born in Brighton in 1942, Blundell was educated at Steyning Grammar School. He was the first in his family to attend university, winning an Open Scholarship to Oxford. He earned a First Class degree in Natural Sciences in 1964, then moved to research in the Department of Chemical Crystallography, first with HM Powell FRS for his DPhil and later working on insulin with Dorothy Hodgkin.[9]


Blundell's early posts were at the University of Oxford and the University of Sussex. In 1976, Blundell joined the Department of Crystallography at Birkbeck, University of London, becoming head of department in 1978.

In 1991, while continuing academic research, he moved further into science administration and policy, as Director General of the Agricultural and Food Research Council (1991–94) and then the founding Chief Executive of the Biotechnology and Biological Sciences Research Council (BBSRC) (1994–1996). He is a former President of the Biosciences Federation (2004–06). In June 2011 he became President of the Science Council.

In 1995 he became the fifth Sir William Dunn Professor of Biochemistry and head of the Department of Biochemistry at the University of Cambridge;[10][11] he currently also holds the Chair of the School of Biological Sciences at that university. He is a fellow of Sidney Sussex College. His specialty is molecular biology and his research on identifying the chemical processes of diseases has led to the development of drugs to treat Aids, cancer, cataracts and diabetes. He is the co-founder of two drug discovery companies, Astex Technology Ltd and Biofabrika.

On 15 September 2010, Blundell, along with 54 other public figures, signed an open letter published in The Guardian, stating their opposition to Pope Benedict XVI's state visit to the UK.[12]

Blundell has been active on environmental issues, first as Chair of the Planning Committee of the Oxford City Council (1970–73), during the time when it stopped the building of a motorway through the city centre, pedestrianised much of the historic centre, and made North Oxford a conservation area. From 1998 to 2005 he was Chair of the Royal Commission on Environmental Pollution,[13] when he oversaw the production of key reports such as those on "Energy -- the Changing Climate", "Chemicals in Products -- Safeguarding the Environment and Human Health", and "Turning the Tide: Addressing the Impact of Fisheries on the Marine Environment".[14] He is a Distinguished Member of the British Humanist Association [7].[15]


Original 1989 structure of the HIV protease dimer, from PDB 3PHV
Glucagon hormone (red) bound to its membrane receptor
Human DNA ligase IV, from PDB 3W5O.

Blundell's research interests lie in elucidating the architecture and function of macromolecules and their multi-component assemblies using methods from biochemistry, protein crystallography, and bioinformatics, with the objectives of understanding biological function, of knowledge-based prediction of structure, and of discovering new therapeutics for cancer and tuberculosis.[16] Systems studied include DNA repair, hormones, growth factors and hormone/receptor interactions, cellular signalling, crystallins (lens proteins), renin and HIV protease. He has contributed 235 crystal structures to the worldwide Protein Data Bank (accessed 3/3/16). At least seven of the Molecule-of-the-Month features at the RCSB site of the worldwide Protein Databank have featured molecular structures solved and studied by the Blundell lab, such as the glucagon hormone shown at left in David Goodsell's drawing,[17][18] nerve growth factor,[19][20] the RAD51-BRCA2 DNA recombination complex,[21][22] and the DNA ligase shown at right.[23][24] His group has written several broadly used bioinformatics programs.[25] [26] [27] [28] He co-authored a textbook on protein crystallography with Louise Johnson,[29] which was translated into French and Russian.

Awards and honours[edit]

Blundell was elected a Fellow of the Royal Society (FRS) in 1984.[30] His nomination reads:

Blundell became one of the first fellows of the Academy of Medical Sciences in 1998.[32] He was elected a member of European Molecular Biology Organisation (EMBO) in 1985; Member Academia Europaea in 1993; Founding Member, Academy of Medical Sciences 1999. International recognition has come in his election as a Foreign Member of the Indian National Science Academy (, the Chilean Academy ( and The World Academy of Sciences TWAS (

Sir Tom Blundell in his office at the University of Cambridge, UK

Blundell has received numerous awards and medals, including the Alcon Award for Vision Research in 1986; Gold Medal, Institute of Biotechnology in 1987; Krebs Medal FEBS 1987; Ciba Medal, Biochemical Society in 1988; Feldberg Prize in Biology and Medicine in 1988; Gold Medal, Society of Chemical Industry in 1996; First Recipient, Pfizer European Prize for Innovation in 1998 and Bernal Lecture, Royal Society 1998.[33] Most recently he received the 2013 Biochemical Society Award and Cambridge University Science Prize called the Philosophical Society Fellows Prize & Lecture 2014.[16] He has been President, UK Biosciences Federation (2003-2009); President, Biochemical Society (2009-2011); and President, UK Science Council (since 2011) (

Blundell's contributions were recognized by a knighthood in 1997. He has been awarded Honorary Doctorate degrees from 16 universities. An audio account of his life and interests is to be found on the BBC radio programme, Desert Island Discs 2006 ( Tom was a guest on Desert Island Discs.[12]


  1. ^ a b c BLUNDELL, Sir Thomas Leon, (Sir Tom). Who's Who 2015 (online Oxford University Press ed.). A & C Black, an imprint of Bloomsbury Publishing plc.  (subscription required)
  2. ^ Hubbard, Tim (1988). The design, expression and characterisation of a novel protein (PhD thesis). University of London. (subscription required)
  3. ^ Overington, John (1991). Knowledge based protein modelling (PhD thesis). London, Birkbeck College. (subscription required)
  4. ^ Pearl, Laurence (1991). Crystallographic studies of endothiapepsin (PhD thesis). London, Birkbeck College. (subscription required)
  5. ^ Sali, Andrej (1984). Modelling three-dimensional structure of a protein from its amino acid sequence (PhD thesis). London, Birkbeck College. 
  6. ^ Blundell, T.; Cutfield, J.; Cutfield, S.; Dodson, E.; Dodson, G.; Hodgkin, D.; Mercola, D.; Vijayan, M. (1971). "Atomic positions in rhombohedral 2-zinc insulin crystals". Nature 231 (5304): 506–511. Bibcode:1971Natur.231..506B. doi:10.1038/231506a0. PMID 4932997. 
  7. ^ BBSRC Chair's biography: Sir Tom Blundell
  8. ^ Find an EMBO member
  9. ^ "Professor Sir Tom Blundell FRS FMedSci". British Humanist Association. Retrieved 22 March 2014. 
  10. ^ List of publications from Microsoft Academic Search
  11. ^ Šali, A.; Blundell, T. L. (1993). "Comparative Protein Modelling by Satisfaction of Spatial Restraints". Journal of Molecular Biology 234 (3): 779–815. doi:10.1006/jmbi.1993.1626. PMID 8254673. 
  12. ^ "Letters: Harsh judgments on the pope and religion". The Guardian (London). 15 September 2010. Retrieved 16 September 2010. 
  13. ^ "Royal Commission on Environmental Pollution". 
  14. ^ "Turning the Tide (RCEP report #25)" (PDF). 
  15. ^ "British Humanist Association - Distinguished supporters:Sir Tom Blundell". 
  16. ^ a b Dept of Biochemistry, Cambridge (includes CV and publications list)
  17. ^ Sasaki K, Dockerill, Adamiak DA, Tickle IJ, Blundell TL (1975). "X-ray analysis of glucagon and its relationship to receptor binding". Nature 257: 751–757. 
  18. ^ "Glucagon Molecule-of-the-Month". 
  19. ^ McDonald N, Lapatto R, Murray-Rust J, Gunning J, Wkodawer A, Blundell TL (1991). "New Protein fold revealed by a 2.3Å resolution crystal structure of nerve growth factor". Nature 345: 411–414. 
  20. ^ "Neurotrophins Molecule-of-the-Month". 
  21. ^ Pellegrini L, Yu DS, Anand S, Lee M, Blundell TL, Venkitaraman AR (2002). "Insights into DNA recombination from the structure of a RAD51-BRCA2 complex". Nature 420: 287–293. 
  22. ^ "RecA and Rad51 Molecule-of-the-Month". 
  23. ^ Ochi T, Gu X, Blundell TL (2013). "Structure of the catalytic region of DNA ligase IV in complex with an artemis fragment sheds light on double-strand break repair". Structure 21: 672–679. 
  24. ^ "DNA ligase Molecule-of-the-Month". 
  25. ^ Lewis, T. E.; Sillitoe, I; Andreeva, A; Blundell, T. L.; Buchan, D. W.; Chothia, C; Cuff, A; Dana, J. M.; Filippis, I; Gough, J; Hunter, S; Jones, D. T.; Kelley, L. A.; Kleywegt, G. J.; Minneci, F; Mitchell, A; Murzin, A. G.; Ochoa-Montaño, B; Rackham, O. J.; Smith, J; Sternberg, M. J.; Velankar, S; Yeats, C; Orengo, C (2013). "Genome3D: A UK collaborative project to annotate genomic sequences with predicted 3D structures based on SCOP and CATH domains". Nucleic Acids Research 41 (Database issue): D499–507. doi:10.1093/nar/gks1266. PMC 3531217. PMID 23203986. 
  26. ^ Lewis, T. E.; Sillitoe, I; Andreeva, A; Blundell, T. L.; Buchan, D. W.; Chothia, C; Cozzetto, D; Dana, J. M.; Filippis, I; Gough, J; Jones, D. T.; Kelley, L. A.; Kleywegt, G. J.; Minneci, F; Mistry, J; Murzin, A. G.; Ochoa-Montaño, B; Oates, M. E.; Punta, M; Rackham, O. J.; Stahlhacke, J; Sternberg, M. J.; Velankar, S; Orengo, C (2015). "Genome3D: Exploiting structure to help users understand their sequences". Nucleic Acids Research 43 (Database issue): D382–6. doi:10.1093/nar/gku973. PMID 25348407. 
  27. ^ Mizuguchi, K.; Deane, C. M.; Blundell, T. L.; Overington, J. P. (1998). "HOMSTRAD: A database of protein structure alignments for homologous families". Protein Science 7 (11): 2469–2471. doi:10.1002/pro.5560071126. PMC 2143859. PMID 9828015. 
  28. ^ Shi, J.; Blundell, T. L.; Mizuguchi, K. (2001). "FUGUE: Sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties". Journal of Molecular Biology 310 (1): 243–257. doi:10.1006/jmbi.2001.4762. PMID 11419950. 
  29. ^ Blundell TL, Johnson LN (1976), Protein Crystallography, Academic Press, ISBN 0121083500 
  30. ^ "Lists of Royal Society Fellows 1660-2007". London: The Royal Society. Archived from the original on March 24, 2010. Retrieved 20 July 2010. 
  31. ^ "EC/1984/03: Blundell, Sir Thomas Leon". London: The Royal Society. Archived from the original on 2014-06-02. 
  32. ^ Academy of Medical Sciences: Fellows: Sir Tom Blundell (accessed 6 January 2009)
  33. ^  Missing or empty |title= (help)
Academic offices
Preceded by
Hans Kornberg
Sir William Dunn Professor of Biochemistry, Cambridge University
1995 - 2009
Succeeded by
Gerard Evan
Government offices
Preceded by
CEO of the Biotechnology and Biological Sciences Research Council
Succeeded by
Ray Baker